Leap Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Leap Therapeutics has a total shareholder equity of $49.0M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $65.0M and $16.1M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$62.82m |
| Equity | US$48.95m |
| Total liabilities | US$16.09m |
| Total assets | US$65.05m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 5MC's short term assets ($63.8M) exceed its short term liabilities ($16.1M).
Long Term Liabilities: 5MC has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: 5MC is debt free.
Reducing Debt: 5MC had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 5MC has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 5MC has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 14.4% each year.